Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Athanasios P. Zis"'
Publikováno v:
Landau, A M, Mallar, C, Clark, C M, Zis, A P & Doudet, D J 2011, ' Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates ', Neuropsychopharmacology, vol. 36, no. 2, pp. 511-8 . https://doi.org/10.1038/npp.2010.182
Electroconvulsive therapy (ECT) is one of the most effective therapies for depression and has beneficial motor effects in parkinsonian patients. However, little is known about the mechanisms of therapeutic action of ECT for either condition. The aim
Autor:
A. Jon Stoessl, Thomas J. Ruth, Vesna Sossi, Peter F. Liddle, Athanasios P. Zis, Michael J. Adam, Raymond W. Lam, Lakshmi N. Yatham
Publikováno v:
British Journal of Psychiatry. 196:474-479
BackgroundBrain serotonin2 (5-hydroxytryptamine2; 5-HT2) receptors were considered potential targets for therapeutic efficacy of electroconvulsive therapy (ECT), but pre-clinical studies showed that electroconvulsive shock up-regulates 5-HT2 receptor
Publikováno v:
The Journal of ECT. 20:3-9
Background: Cognitive impairments are the main complication after electroconvulsive therapy (ECT). Modification of treatment parameters has been shown to affect the magnitude of these impairments, but the role of anesthetic type remains unclear. This
Publikováno v:
Psychopharmacology. 159:196-202
Rationale: The withdrawal of humans from high doses of psychostimulant drugs can result in a transient syndrome which appears isomorphic to endogenous depression. One of the more prominent symptoms is a loss of hedonic capacity; in animals, the anhed
Publikováno v:
Journal of Affective Disorders. 63:123-132
Objective: In DSM-IV, winter seasonal affective disorder (SAD) is classified as a seasonal pattern of recurrent major depressive episodes in winter with full remission of symptoms in summer. However, other groups with ''winter depression'' have been
Publikováno v:
Journal of Affective Disorders. 54:295-301
Background: The selective 5-HT1A receptor agonist ipsapirone causes dose-dependent decrease in body temperature and increase in adrenocorticotropic hormone (ACTH) and cortisol release in humans. These responses are attenuated by 5-HT1A receptor antag
Autor:
Athanasios P. Zis, Raymond W. Lam, Shaila Misri, Lakshmi N. Yatham, Diana Carter, Annie J. Kuan
Publikováno v:
Psychiatry Research. 86:185-192
Previous studies suggest that light therapy, as used to treat seasonal affective disorder, may be beneficial for pre-menstrual depressive disorders. We conducted a six-menstrual cycle randomized, double-blind, counter-balanced, crossover study of dim
Autor:
Athanasios P. Zis, Raymond W. Lam, Lakshmi N. Yatham, I-Shin Shiah, Edwin M. Tam, Heather A. Robertson
Publikováno v:
Psychoneuroendocrinology. 24:143-153
There is evidence for γ-aminobutyric acid (GABA) dysfunction in the pathophysiology and treatment response of patients with major depression, but this has not been studied in seasonal affective disorder (SAD). Growth hormone (GH) response to a chall
Publikováno v:
Neuropsychopharmacology. 18:370-376
The effect of divalproex sodium (DVP) on gamma-aminobutyric acid-B (GABAB) receptor function in humans was assessed by measuring growth hormone (GH) responses to a challenge with a GABAB receptor agonist, baclofen, in 10 male healthy volunteers. Each
Publikováno v:
Neuropsychobiology. 38:6-12
To examine if 5-HT1A receptor function is involved in the pathophysiology of bipolar depression, we measured the cortisol, hypothermic and behavioral responses to ipsapirone, a 5-HT1A receptor agonist, in 8 patients with bipolar depression and 26 nor